Navigation Links
Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimer's DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin
Date:8/16/2011

> bacteria to flourish. Older patients in particular are at risk for CDAD, potentially because of a weakened immune system or the presence of underlying disease. Approximately two-thirds of CDAD patients are 65 years of age or older.

Current estimates suggest CDAD may affect more than 700,000 people in the U.S. each year, though the incidence may be higher as many cases are believed to be undiagnosed, untreated and underreported. The disease adds significant costs and burden to the U.S. healthcare system with estimates for medical treatment and hospital stays associated with CDAD reaching as much as $3.8 billion every year. Historically, approximately 20% to 30% of CDAD patients who initially respond to treatment experience a clinical recurrence.

About Optimer

Optimer Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing innovative hospital specialty products that have a positive impact on society. Optimer has developed and commercialized DIFICID™ (fidaxomicin) tablets, an FDA-approved antibacterial drug for the treatment of adult patients with Clostridium difficile-associated diarrhea (CDAD). Optimer has filed a marketing authorization application with the European Medicines Agency for fidaxomicin. Optimer's clinical pipeline includes Pruvel™, a product in the fluoroquinolone class of antibiotics that has completed Phase 3 trials as a treatment for infectious diarrhea. Additional information can be found at http://www.optimerpharma.com.

Forward Looking Statements

Statements included in this press release that are not a description of historical facts are forward-looking statements, including without limitation statements related to DIFICID's ability to mitigate the impact of concomitant antibiotics on response to CDAD treatment. Words such as "believes", "would", "anticipates", "plans", "expects"
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... June 2, 2015 Today AmerisourceBergen, a global ... distribution centers in Olive Branch, MS ... Newburgh, NY . The facilities will operate ... improve product access, increase supply chain efficiency and enhance ... of the company,s ongoing investments, more than $1 billion ...
(Date:6/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/jrlgdj/electrophysiology ) has ... by Product {Diagnostic Catheter (Conventional, Advanced, Ultrasound)), Ablation ... Generator, ICE, X-ray)) & Indication (AF, VT, WPW) ... their offering. The global electrophysiology (EP) ... CAGR of 10.3% from 2014 to 2019 ...
(Date:6/2/2015)... MELBOURNE, Australia , June 2, 2015 /PRNewswire/ ... has successfully raised AUD$14.8 million to rapidly ... its lead Personal KinetiGraph™ (PKG™) mobile health ... Partners has contributed further capital in the ... funds, industry veterans, high net worth individuals ...
Breaking Medicine Technology:AmerisourceBergen to Build Three New Distribution Centers 2Global Electrophysiology Market Report 2015-2019 - Product, Ablation Catheter, Lab Devices & Indication Analysis 2Global Electrophysiology Market Report 2015-2019 - Product, Ablation Catheter, Lab Devices & Indication Analysis 3Global Kinetics Corporation Closes AUD$14.8 Million Capital Raising 2Global Kinetics Corporation Closes AUD$14.8 Million Capital Raising 3
... 2011 Tocagen Inc. today announced the ... such as those with glioblastoma multiforme (GBM, Grade 4), ... The multicenter, open-label study is evaluating the safety ... administered intratumorally followed by cycles of the prodrug 5-fluorocytosine ...
... KNDL ), a leading, global full-service ... of Pierre Geoffroy, MD, CM, MSc, FCFP as ... brings nearly two decades of clinical development experience ... the development of Early Stage programs for customers ...
Cached Medicine Technology:Tocagen's First-in-Human Clinical Trial of Toca 511 Enrolling Patients with High Grade Glioma 2Kendle Appoints Pierre Geoffroy, MD, CM, MSc, FCFP Vice President, Early Stage 2Kendle Appoints Pierre Geoffroy, MD, CM, MSc, FCFP Vice President, Early Stage 3
(Date:6/2/2015)... Acara Partners has seen a spike in demand for ... as is now required by recent Google search algorithm changes. ... several new clients in the medical aesthetics vertical, are anxious ... meet Google’s new requirements,” commented Fran Acunzo, CEO of Acara ... education, non-profits, and the business world.” , Back in ...
(Date:6/2/2015)... Vancouver, BC (PRWEB) June 02, 2015 ... to announce the opening of Surrey’s first ... cities and boasts a diverse, young community, ... communities. http://www.theglobeandmail.com/news/british-columbia/four-reasons-bcs-fastest-growing-city-is-a-political-powerhouse/article21408253/ , Until now ... have had to come into Vancouver ...
(Date:6/2/2015)... 2015 ANT Wireless, proven innovator ... Pole Engineering’s (NPE) announcement of three next generation ... WASP-PoE-2 and WASP-PoE-3. WASP is a standalone ANT ... bridge solution that allows data collected from low-power ... Ethernet networks. , The new generation ...
(Date:6/2/2015)... TU-Automotive Detroit is the biggest dedicated B2B connected ... senior execs from GM, Chrysler, Mercedes, Ford, TomTom, Zipcar, ... status update on the automotive technology industry and a ... to secure one of the remaining passes. , Justin ... There are 70 sessions looking across the connected car ...
(Date:6/2/2015)... CRN International has been named a 2015 Company Partner ... Connecticut state program that takes active steps to train, coach ... companies. , Platform to Employment is being delivered by ... Labor. CRN, a 40-year-old radio marketing company near New Haven, ... for its “hard work and dedication.” , CRN recently took ...
Breaking Medicine News(10 mins):Health News:Acara Partners Expands Website and Digital Offerings 2Health News:Olive Fertility Centre Opens First Fertility Clinic in Surrey BC 2Health News:ANT Technology Incorporated in Second Generation WASP Bridge Products 2Health News:ANT Technology Incorporated in Second Generation WASP Bridge Products 3Health News:The Connected Car’s Biggest Event is Here – TU-Automotive Detroit 2015 2Health News:CRN Named Company Partner of the Year by CT Employment Program 2
... Angeles Universities, VSP(R) Vision Care and Transitions Optical ... Their Eye Health, PINELLAS PARK, Fla., Nov. 7 ... Career College, Hacienda La,Puente Adult Education and VSP(R) Vision ... Hispanic community at the American Diabetes,Association,s Feria de Salud ...
... officials,traveling the state to gain insight and raise public ... to Bedford, Blair and Centre,counties today., The tour ... James is part of the Strategy for Agriculture and ... to address,food safety and defense from the farm to ...
... BioSpecifics,Technologies Corp. (OTC Bulletin Board: BSTC.OB), a ... that BioSpecifics, President, Tom Wegman, will present a,corporate ... Annual Healthcare,Conference on Wednesday, November 12, 2008, at ... New York, NY., A live webcast of ...
... Associates Also Names Kaiser Permanente "Highest in,Member Satisfaction" ... 7 Kaiser Permanente Colorado is the,top-ranked commercial ... according to a joint ranking by U.S. News ... Assurance (NCQA)., To view the Multimedia News ...
... October 31, 2008 -- Children under the age of three ... behavioral or developmental problems later compared to children who had ... at Columbia University Mailman School of Public Health and the ... children who were born into the New York State Medicaid ...
... by Charlie Rose at National Health Science Summit, ... the leader,in disease prevention, today announced Dr. Valentin ... its first-ever Global Prevention Prize.,The Prize was presented ... during the inaugural National Health Science Summit held ...
Cached Medicine News:Health News:Transitions Optical to Provide Free Vision Screenings at the American Diabetes Association's Feria de Salud por tu Familia(TM) 2Health News:Transitions Optical to Provide Free Vision Screenings at the American Diabetes Association's Feria de Salud por tu Familia(TM) 3Health News:Rendell Cabinet Secretaries Address Food Safety Concerns During Central PA Tour 2Health News:Audio: Kaiser Permanente is Colorado's Top Commercial and Medicare Plan on U.S. News & World Report/NCQA 'America's Best Health Plans' List 2Health News:Audio: Kaiser Permanente is Colorado's Top Commercial and Medicare Plan on U.S. News & World Report/NCQA 'America's Best Health Plans' List 3Health News:General anesthesia for hernia surgery in children and risk of later developmental problems 2Health News:U.S. Preventive Medicine(R) Awards Inaugural Global Prevention Prize to Dr. Valentin Fuster of Mount Sinai Heart 2Health News:U.S. Preventive Medicine(R) Awards Inaugural Global Prevention Prize to Dr. Valentin Fuster of Mount Sinai Heart 3
... Innovators in Anesthesia and Respiratory Products, ... quality medical devices for Anesthesia and Respiratory ... manufacture products that enhance the clinician's ability ... close attention to the bottom line. , ...
... The Raindrop® medication nebulizer achieves optimum ... MMAD particle size range is 1.04-1.10 µ ... compressor or air outlet., ,As the ... gives healthcare providers the assurance of proven ...
... practitioners consider the HOPE nebulizer the gold standard ... made to put everything together in one convenient ... is our #11320 Adult HOPE Kit which contains ... and pediatric aerosol mask all in one set ...
... nebulizers offer a spill-proof design and effective ... 45° angle. All medical nebulizers are free-standing ... of configurations are available., ,All Portex® ... ,Portex® medication nebulizers feature consistently fine misting ...
Medicine Products: